Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no longer in shortage after nearly two years. Pharmacies that sold ...

Three Fool.com contributors have identified what they believe are no-brainer growth stocks to buy in October. Here's why they ...

In a year and a half, Eli Lilly (NYSE: LLY) has roughly doubled in value. It is now the most valuable pharmaceutical company ...

Eli Lilly and Company (NYSE:LLY – Get Free Report)’s stock price was up 1.1% during trading on Friday after Truist Financial raised their price target on the stock from $1,000.00 to $1,033.00. Truist ...

If you're looking for two magnificent growth stocks to start your long-term portfolio (or add to a portfolio) and have $500 ...

The future of the weight loss market might not revolve around GLP-1 drugs.

New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.

In a report released on October 10, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on Novo Nordisk (0QIU – Research ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Anders Carlson, Matt Orzech welcome challenges from Greg Joseph, Peter Bowden ...

Elon Musk Unveils the Long-Awaited Robotaxi and Tesla's Autonomous Future ...

Since early September, beachgoers have been reporting sightings of the unusual substance, leaving officials scrambling to determine its origin and composition.